Clinical Trial

Chronic Spontaneous Urticaria (Hives)

For adults (≥ 18 yo) with chronic spontaneous urticaria (subcutaneous study drug)

Recruiting Trials

CLINICAL TRIAL

Chronic Spontaneous Urticaria

(Hives) Trial

Phase 3b | Oral tablet | 52 week treatment period

Trial ID: NCT06042478

RECRUITING


  • ≥ 18 years old
  • Diagnosed with Chronic Spontaneous Urticaria for ≥ 6 months
  • Must have experienced the presence of itching and hives for > 6 consecutive weeks, and symptomatic within 3 months prior to the trial

Exclusion Criteria:

  • Received Remibrutinib of other BTK inhibitors
  • Received anti-IgE therapies, including Ligelizumab or Omalizumab
  • Currently on anticoagulant medication or dual anti-platelet therapy

Learn More About This Trial

Contact Us